Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$62.3
Market cap
$1.92B
P/E Ratio
19.41
Dividend/share
$0.8
EPS
$3.21
Enterprise value
$2.86B
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties,
Highlights
The stock's price to earnings (P/E) is 50% less than its last 4 quarters average of 38.9
CNMD's quick ratio is up by 38% YoY and by 7% QoQ
Key stats
What are the main financial stats of CNMD
Market
Valuations
Earnings
Shares outstanding
30.83M
Market cap
$1.92B
Enterprise value
$2.86B
Price to earnings (P/E)
19.41
Price to book (P/B)
2.18
Price to sales (P/S)
1.5
EV/EBIT
17.57
EV/EBITDA
15.98
EV/Sales
2.24
Revenue
$1.28B
EBIT
$162.61M
EBITDA
$178.8M
Free cash flow
$159.08M
Per share
Balance sheet
Liquidity
EPS
$3.21
Free cash flow per share
$5.16
Book value per share
$28.63
Revenue per share
$41.41
TBVPS
$27.46
Total assets
$2.29B
Total liabilities
$1.4B
Debt
$965.89M
Equity
$881.83M
Working capital
$357.42M
Debt to equity
1.1
Current ratio
2.34
Quick ratio
1.01
Net debt/EBITDA
5.24
Margins
Efficiency
Dividend
EBITDA margin
14%
Gross margin
55.3%
Net margin
7.7%
Operating margin
12.7%
Return on assets
4.3%
Return on equity
11.7%
Return on invested capital
10.9%
Return on capital employed
8.1%
Return on sales
12.7%
Dividend yield
1.28%
DPS
$0.8
Payout ratio
24.9%
CNMD stock price
How has the CONMED stock price performed over time
Intraday
-1.19%
1 week
-4.86%
1 month
-17.48%
1 year
-33.87%
YTD
-43.11%
QTD
-13.38%
Financial performance
How have CONMED's revenue and profit performed over time
Revenue
$1.28B
Gross profit
$705.93M
Operating income
$162.61M
Net income
$98.59M
Gross margin
55.3%
Net margin
7.7%
The operating income has soared by 157% year-on-year and by 14% since the previous quarter
The operating margin has surged by 127% year-on-year and by 12% since the previous quarter
The net income is up by 20% since the previous quarter and by 12% year-on-year
The company's net margin rose by 18% QoQ
Growth
What is CONMED's growth rate over time
Valuation
What is CONMED stock price valuation
P/E
19.41
P/B
2.18
P/S
1.5
EV/EBIT
17.57
EV/EBITDA
15.98
EV/Sales
2.24
The stock's price to earnings (P/E) is 50% less than its last 4 quarters average of 38.9
CNMD's EPS is up by 19% QoQ and by 10% YoY
The stock's price to book (P/B) is 46% less than its 5-year quarterly average of 4.1 and 33% less than its last 4 quarters average of 3.3
CNMD's equity is up by 13% YoY and by 3.2% from the previous quarter
CNMD's P/S is 49% less than its 5-year quarterly average of 3.0 and 31% less than its last 4 quarters average of 2.2
CNMD's revenue is up by 12% year-on-year
Efficiency
How efficient is CONMED business performance
CNMD's return on invested capital has surged by 166% year-on-year and by 14% since the previous quarter
CNMD's ROS has soared by 127% YoY and by 12% QoQ
CNMD's return on assets is up by 19% since the previous quarter and by 13% year-on-year
The ROE has grown by 16% from the previous quarter
Dividends
What is CNMD's dividend history
DPS
$0.8
Dividend yield
1.28%
Payout ratio
24.9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did CONMED financials performed over time
CNMD's total assets is 63% greater than its total liabilities
CNMD's quick ratio is up by 38% YoY and by 7% QoQ
The current ratio has grown by 34% YoY and by 7% from the previous quarter
The company's debt is 10% higher than its equity
The company's debt to equity fell by 17% YoY and by 5% QoQ
CNMD's equity is up by 13% YoY and by 3.2% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.